U.S. markets closed

Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020

AUSTIN, Texas, Feb. 13, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President & CEO, and Harriss Currie, Senior Vice President of Finance and CFO, plan to participate at three investor conferences in March 2020.

  • Morgan Stanley European MedTech & Services Conference in London, England on March 3, 2020: one-on-one investor meetings. Webcasts are not available for this Morgan Stanley event.
  • Barclays Global Healthcare Conference in Miami, Florida on March 11, 2020: one-on-one investor meetings and live webcast of "fireside chat" with an analyst and investors on March 11 at 10:45 a.m. to 11:10am Eastern Time. The webcast may be accessed at Luminex's website at investor.luminexcorp.com. The session will be archived for six months on the website using the 'replay' link.
  • BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, Utah on March 19, 2020: one-on-one investor meetings. Webcasts are not available for this BTIG event.

About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at luminexcorp.com.

Harriss Currie
Senior Vice President of Finance and Chief Financial Officer

Jeff Christensen
Senior Director, Investor Relations

Luminex logo. (PRNewsFoto/Luminex Corporation)



View original content to download multimedia:http://www.prnewswire.com/news-releases/luminex-corporation-to-participate-at-upcoming-healthcare-investor-conferences-in-march-2020-301004866.html

SOURCE Luminex Corporation